138 related articles for article (PubMed ID: 4930644)
1. [Angiographic follow-up examination findings in arteriosclerosis obliterans with and without long-term anticoagulant therapy].
Schmidt KH; Schmidt H; Heine H; Porstmann W; Driese H
Dtsch Gesundheitsw; 1971 Feb; 26(8):346-9. PubMed ID: 4930644
[No Abstract] [Full Text] [Related]
2. Obliterative arterial disease of the lower limbs. IV. Evaluation of long-term anticoagulant therapy.
Tillgren C
Acta Med Scand; 1965 Aug; 178(2):203-19. PubMed ID: 4158084
[No Abstract] [Full Text] [Related]
3. [Long-term use of indirect anticoagulants in patients with obliterating atherosclerosis of peripheral arteries].
Khaĭne Kh; Norden K; Makh Kh; Shmidt Kh
Kardiologiia; 1985 Sep; 25(9):61-3. PubMed ID: 3908781
[No Abstract] [Full Text] [Related]
4. [Angioprotective activity of mexicor in atherosclerosis obliterans of the lower limbs].
Inchina VI; Smirnov LD; Romanov MD; Kokoreva EV; Morozov MIu
Angiol Sosud Khir; 2007; 13(3):17-20. PubMed ID: 18382390
[TBL] [Abstract][Full Text] [Related]
5. Long-term effect of anticoagulants in obliterative arterial disease of the legs.
Tillgren C; Lund F
Scand J Clin Lab Invest Suppl; 1967; 99():184-6. PubMed ID: 6056920
[No Abstract] [Full Text] [Related]
6. [Personal experience on indirect long-term anticoagulant therapy in ambulatory peripheral chronic arteriosclersis obliterans patients].
Raso AM; Silvestrini P
Angiologia; 1968; 20(6):301-16. PubMed ID: 5747170
[No Abstract] [Full Text] [Related]
7. [Results of a long-term anticoagulant therapy in patients with arteriosclerosis obliterans compared to a collective group with myocardial infarct].
Schmidt HH; Heine H; Zimmermann B; Hackenberger F
Z Gesamte Inn Med; 1971 Oct; 26(20):Suppl 20:275-7. PubMed ID: 5004145
[No Abstract] [Full Text] [Related]
8. [Problems in the use of anticoagulants in severe arterial occlusive diseases of the limbs].
Linke H
Z Gesamte Inn Med; 1970 Aug; 25(15):688-93. PubMed ID: 5527533
[No Abstract] [Full Text] [Related]
9. Heparin and exercise treatment in a patient with arteriosclerosis obliterans.
Shioji K; Fujita M; Yamada T; Matsuda T; Nohara R; Sasayama S
Jpn Circ J; 1997 Aug; 61(8):715-8. PubMed ID: 9276778
[TBL] [Abstract][Full Text] [Related]
10. [Nicotinyl in the treatment of arteriosclerosis obliterans of the lower limbs].
Grodzińska L; Basista M; Byrska-Danek A; Kostka-Trabka E
Pol Tyg Lek; 1984 Jun 12-25; 39(25-26):879-81. PubMed ID: 6387654
[No Abstract] [Full Text] [Related]
11. [Diprophyllinum prolongatum (Polfa, Cracow) in the treatment of arteriosclerosis obliterans of the lower limbs].
Kostka-Trabka E; Grodzińska L; Dembińska-Kieć A; Basista M; Telesz E
Przegl Lek; 1983; 40(7):563-6. PubMed ID: 6356236
[No Abstract] [Full Text] [Related]
12. [On the differential diagnosis of arterial obliterating diseases of the upper extremities].
Hofmeister L
Munch Med Wochenschr; 1969 May; 111(22):1259-64. PubMed ID: 5819096
[No Abstract] [Full Text] [Related]
13. [Internal conservative treatment of obliterative arteriopathies of the lower limbs].
Toth L
Med Pregl; 1975; 28(3-4):181-3. PubMed ID: 1177851
[No Abstract] [Full Text] [Related]
14. [Arteriosclerosis: a challenge for the surgeon. Prevention and postoperative care (author's transl)].
Rau G
Langenbecks Arch Chir; 1975 Nov; 339():175-85. PubMed ID: 1207298
[TBL] [Abstract][Full Text] [Related]
15. [Effect of long-term pentoxifylline treatment on selected parameters of the fibrinolytic system in patients with arteriosclerosis obliterans of the legs].
Berent H; Kancelarczyk WL; Zebrowski M; Uchman B
Pol Tyg Lek; 1988 Jun; 43(24):776-8. PubMed ID: 3237518
[No Abstract] [Full Text] [Related]
16. [Clinical rheovasographic comparisons in arteriosclerosis obliterans of the lower extremities].
Akhverdian RA; Nagapetian IO
Zh Eksp Klin Med; 1972; 12(4):76-83. PubMed ID: 4668897
[No Abstract] [Full Text] [Related]
17. [Serum lipid levels in patients with arteriosclerosis obliterans of the legs during treatment with pentoxifylline].
Kuczyńska K; Zebrowski M; Kancelarczyk WL; Rymaszewski Z
Pol Tyg Lek; 1988 Aug; 43(34):1092-4. PubMed ID: 3075031
[No Abstract] [Full Text] [Related]
18. [Use of etofibrate in the treatment of patients with hyperlipidemia and arteriosclerosis obliterans of the legs].
Dembińska-Kieć A; Kostka-Trabka E; Grodzińska L; Bieroń K; Kedzior A; Basista M; Zmuda A; Trabka E; Sławiński M; Czarnecka B
Pol Tyg Lek; 1987 Dec 21-28; 42(51-52):1643-8. PubMed ID: 3330798
[No Abstract] [Full Text] [Related]
19. [Antithrombotic prophylaxis of the complications of arteriosclerosis obliterans].
Heine H; Norden K; Heinemann L; Stepanauskas M; Schmidt H
Kardiologiia; 1981 Aug; 21(8):76-80. PubMed ID: 7289389
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between roentgenologic bone changes and some indices of the functional state of blood vessels in patients with arteriosclerosis obliterans of the lower extremities].
Kasparian RM
Zh Eksp Klin Med; 1971; 11(1):66-74. PubMed ID: 5096749
[No Abstract] [Full Text] [Related]
[Next] [New Search]
